Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
FASEB J ; 27(12): 4834-43, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23970798

ABSTRACT

In previous studies, the oligo-acyl-lysyl (OAK) C12(ω7)K-ß12 added to cultures of gram-positive bacteria exerted a bacteriostatic activity that was associated with membrane depolarization, even at high concentrations. Here, we report that multidrug-resistant Staphylococcus aureus strains, unlike other gram-positive species, have reverted to the sensitive phenotype when exposed to subminimal inhibitory concentrations (sub-MICs) of the OAK, thereby increasing antibiotics potency by up to 3 orders of magnitude. Such chemosensitization was achieved using either cytoplasm or cell-wall targeting antibiotics. Moreover, eventual emergence of resistance to antibiotics was significantly delayed. Using the mouse peritonitis-sepsis model, we show that on single-dose administration of oxacillin and OAK combinations, death induced by a lethal staphylococcal infection was prevented in a synergistic manner, thereby supporting the likelihood for synergism to persist under in vivo conditions. Toward illuminating the molecular basis for these observations, we present data arguing that sub-MIC OAK interactions with the plasma membrane can inhibit proton-dependent signal transduction responsible for expression and export of resistance factors, as demonstrated for ß-lactamase and PBP2a. Collectively, the data reveal a potentially useful approach for overcoming antibiotic resistance and for preventing resistance from emerging as readily as when bacteria are exposed to an antibiotic alone.


Subject(s)
Anti-Bacterial Agents/pharmacology , Drug Resistance, Multiple, Bacterial , Oligopeptides/pharmacology , Oxacillin/pharmacology , Staphylococcus aureus/drug effects , Animals , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/therapeutic use , Cell Membrane/drug effects , Cell Membrane/metabolism , Dose-Response Relationship, Drug , Drug Combinations , Drug Synergism , Male , Mice , Mice, Inbred ICR , Oligopeptides/administration & dosage , Oligopeptides/chemical synthesis , Oligopeptides/therapeutic use , Oxacillin/administration & dosage , Oxacillin/therapeutic use , Penicillin-Binding Proteins/genetics , Penicillin-Binding Proteins/metabolism , Peritonitis/drug therapy , R Factors/drug effects , Sepsis/drug therapy , Signal Transduction , Staphylococcus aureus/metabolism , Transcription, Genetic , beta-Lactamases/genetics , beta-Lactamases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL